The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Metered Dose Inhaler Devices Market Over The Period 2026–2030?
The metered dose inhaler devices market size has demonstrated strong growth in recent years. It is projected to expand from $16.23 billion in 2025 to $17.12 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.5%. This historical growth can be ascribed to factors such as the increasing prevalence of asthma, a rise in COPD incidence, the extensive use of inhalation therapy, physician preference for mdIs, and the availability of generic inhalers.
The metered dose inhaler devices market size is anticipated to expand significantly in the upcoming years, with projections indicating it will reach $21.06 billion in 2030, growing at a compound annual growth rate (CAGR) of 5.3%. This growth during the forecast period is primarily driven by the expansion of smart inhalers, environmental regulations concerning propellants, the increase in homecare treatment, the demand for digital adherence monitoring, and the emergence of new respiratory therapies. Key trends expected in the forecast period include smart dose tracking inhalers, breath-actuated inhalation technology, designs for compact and portable devices, enhanced dose accuracy, and the adoption of eco-friendly propellants.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20878&type=smp
What Underlying Factors Are Accelerating The Growth Of The Metered Dose Inhaler Devices Market?
The expanding occurrence of chronic obstructive pulmonary diseases is anticipated to boost the expansion of the Metered Dose Inhaler Devices Market in the coming period. Chronic obstructive pulmonary disease (COPD) is a progressive condition affecting the lungs, marked by restricted airflow, frequently resulting from prolonged exposure to irritants like cigarette smoke, causing symptoms such as breathlessness, coughing, and wheezing. The rising incidence of COPD stems from various factors, including tobacco consumption, environmental pollution, an aging demographic, and belated diagnosis or intervention. Metered dose inhaler (MDI) devices assist in managing COPD by directly administering medicine to the lungs, offering rapid alleviation and enhancing respiratory function. For example, the National Institutes of Health, a US government body, reported in December 2023 that the number of COPD cases is forecast to increase from 532 million in 2030 to a total of 592 million by 2050. Consequently, the growing prevalence of chronic obstructive pulmonary diseases is fueling the expansion of the Metered Dose Inhaler Devices Market.
How Is The Metered Dose Inhaler Devices Market Divided Into Its Major Segments?
The metered dose inhaler devices market covered in this report is segmented –
1) By Type: Desktop Metered Dose Inhaler Devices, Portable Metered Dose Inhaler Devices, Other Types
2) By Distribution Channel: Online, Offline
3) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Other Applications
4) By End-User: Hospitals, Clinics, Homecare Settings, Other End Users
Subsegments:
1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices, High-performance desktop MDI devices, Smart desktop MDI devices
2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices, Advanced portable MDI devices, Smart portable MDI devices
3) By Other Types: Nebulizer-Based MDI devices, Dry powder inhaler (DPI) combined devices, Soft mist inhaler (SMI) devices, Other specialized MDI devices
How Are Trends Transforming The Metered Dose Inhaler Devices Market Landscape?
Leading companies in the metered dose inhaler devices market are concentrating on developing advanced technological solutions, such as pressurized metered dose inhalers, to improve drug delivery efficiency and patient compliance. Pressurized metered-dose inhalers (pMDIs) are inhalation devices that administer a precise dose of medication in aerosol form, utilizing a pressurized propellant. For example, in July 2023, Lupin Limited, an India-based pharmaceutical company, introduced Luforbec 100/6, a pressurized metered dose inhaler (pMDI) for treating adult asthma and chronic obstructive pulmonary disease (COPD) in Germany. This product combines beclometasone (100 µg) and formoterol (6 µg), offering an effective option for patients who require combination therapy. Notably, Luforbec is available at a price approximately 47% lower than the fixed reference price, thereby increasing its accessibility. Considering that asthma affects about 5% of adults in Germany, this launch emphasizes Lupin’s commitment to addressing critical healthcare requirements and enhancing patient outcomes in respiratory care.
Who Are The Prominent Organizations Shaping The Metered Dose Inhaler Devices Market?
Major companies operating in the metered dose inhaler devices market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline plc, 3M Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Inc., AptarGroup Inc., Philips Healthcare, Chiesi Farmaceutici S.p.A., Cipla Limited, Gerresheimer AG, Zydus Lifesciences Limited, Mylan N.V., Nemera, Beximco Pharmaceuticals Limited, Cohero Health Inc., Bespak Europe Ltd., Trudell Medical International, Iconovo AB
Read the full metered dose inhaler devices market report here:
https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report
Which Region Is Projected To Dominate The Metered Dose Inhaler Devices Market During The Forecast Period?
North America was the largest region in the metered dose inhaler devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metered dose inhaler devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Metered Dose Inhaler Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20878&type=smp
Browse Through More Reports Similar to the Global Metered Dose Inhaler Devices Market 2026, By The Business Research Company
Respiratory Inhaler Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report
Smart Inhalers Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report
Albuterol Market Report 2026
https://www.thebusinessresearchcompany.com/report/albuterol-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model